Levels of circulating adiponectin are decreased in obesity and metabolic syndrome, likely contributing to the development of insulin resistance (Arita et al., 1999; Hotta et al., 2001; Yang et al., 2001). Here, ADIPOQ is linked to Insulin resistance.